Currently holds a position at Evofem Biosciences Inc
Position | Company | Period |
---|---|---|
General Counsel, Secretary | Evofem Biosciences Inc | Jan. 17, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-10-02 | 2023-09-29 |
Silverback Therapeutics Inc
(SBTX)
|
B Purchase |
46,258
+107.7%
3.78174,994 USD |
46,258 +107.7% | 3.78 | 174,994 USD | |
2023-10-02 | 2023-09-28 |
Silverback Therapeutics Inc
(SBTX)
|
PP Planned purchase |
40,000
+1347.3%
3.62144,960 USD |
40,000 +1347.3% | 3.62 | 144,960 USD | |
2021-12-20 | 2021-12-20 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
25,000
+8.0%
0.399,725 USD |
25,000 +8.0% | 0.39 | 9,725 USD | |
2021-06-10 | 2021-06-10 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
10,000
+3.3%
1.0310,250 USD |
10,000 +3.3% | 1.03 | 10,250 USD | |
2020-11-18 | 2020-11-17 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
9,090
+6.8%
2.2019,998 USD |
9,090 +6.8% | 2.20 | 19,998 USD | |
2018-08-21 | 2018-08-21 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
500
+0.7%
2.271,135 USD |
500 +0.7% | 2.27 | 1,135 USD | |
2018-08-21 | 2018-08-20 |
Evofem Biosciences Inc
(EVFM)
|
B Purchase |
4,500
+6.4%
2.209,900 USD |
4,500 +6.4% | 2.20 | 9,900 USD |